Clinical Trial Update: Proof of Concept Study Evaluating BP1.3656 in Patients With Fatigue Following Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept study evaluating BP1.3656 for fatigue after ischemic stroke has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• BP1.3656

Snippet

Sponsor: Bioprojet | Conditions: Fatigue | Phase 2 | Status: TERMINATED